Sangon Biotech: difference between revisions
Diff·revision 24 → 25·21:46, 15 Apr 2025
Difference between revision 24 and revision 25 of Sangon Biotech. 3 lines changed; the page grew by 242 bytes.
| Revision 24 — 12:07, 6 Apr 2025 ChainCustodyChad (talk) remove weasel wording 6,639 bytes +377 | Revision 25 — 21:46, 15 Apr 2025 LotTraceLuka (talk) add comparator rate 6,881 bytes +242 | ||
|---|---|---|---|
| 49 | The reagent and oligonucleotide lines place this organisation in a different category from most covered here. Its inclusion in this wiki's supplier articles reflects its peptide listings, not the whole of its business.{{r|selfpub}} | 49 | The reagent and oligonucleotide lines place this organisation in a different category from most covered here. Its inclusion in this wiki's supplier articles reflects its peptide listings, not the whole of its business.{{r|selfpub}} |
| 50 | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on SGN peptide material to July 2026 are moderate in number. Reported [[Area percent purity|area percent]] figures have been high and consistent with accompanying certificates.{{r|reports}} | |
| + | 53 | ||
| 51 | == References == | 54 | == References == |
| 52 | {{reflist}} | 55 | {{reflist}} |